Immunosuppression by anti-CD8 (Ly-2.1) MAb conjugated to idarubicin: studies in the mouse heart graft model.
Mottram
P L
PL
Department of Surgery, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia.
Pietersz
G A
GA
Purcell
L J
LJ
Clunie
G J
GJ
McKenzie
I F
IF
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology*; D016827:CD8 Antigens; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology*; D015255:Idarubicin / Q000627:therapeutic use*; D007165:Immunosuppression Therapy; D051379:Mice; D008807:Mice, Inbred BALB C; D008808:Mice, Inbred CBA; D016042:Transplantation, Heterotopic
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D016827:CD8 Antigens; D015255:Idarubicin